116 related articles for article (PubMed ID: 14980636)
21. Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson's disease.
Kozikowski AP; Gaisina IN; Petukhov PA; Sridhar J; King LT; Blond SY; Duka T; Rusnak M; Sidhu A
ChemMedChem; 2006 Feb; 1(2):256-66. PubMed ID: 16892358
[TBL] [Abstract][Full Text] [Related]
22. Anti-obesity effects of 3-hydroxychromone derivative, a novel small-molecule inhibitor of glycogen synthase kinase-3.
Lee S; Yang WK; Song JH; Ra YM; Jeong JH; Choe W; Kang I; Kim SS; Ha J
Biochem Pharmacol; 2013 Apr; 85(7):965-76. PubMed ID: 23337568
[TBL] [Abstract][Full Text] [Related]
23. Novel indolylindazolylmaleimides as inhibitors of protein kinase C-beta: synthesis, biological activity, and cardiovascular safety.
Zhang HC; Derian CK; McComsey DF; White KB; Ye H; Hecker LR; Li J; Addo MF; Croll D; Eckardt AJ; Smith CE; Li Q; Cheung WM; Conway BR; Emanuel S; Demarest KT; Andrade-Gordon P; Damiano BP; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1725-8. PubMed ID: 15771419
[TBL] [Abstract][Full Text] [Related]
24. Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3α.
Lo Monte F; Kramer T; Gu J; Anumala UR; Marinelli L; La Pietra V; Novellino E; Franco B; Demedts D; Van Leuven F; Fuertes A; Dominguez JM; Plotkin B; Eldar-Finkelman H; Schmidt B
J Med Chem; 2012 May; 55(9):4407-24. PubMed ID: 22533818
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Improved Glycogen Synthase Kinase-3α Inhibitors in Models of Acute Myeloid Leukemia.
Neumann T; Benajiba L; Göring S; Stegmaier K; Schmidt B
J Med Chem; 2015 Nov; 58(22):8907-19. PubMed ID: 26496242
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and biological evaluation of 1-phenylpyrazolo[3,4-e]pyrrolo[3,4-g]indolizine-4,6(1H,5H)-diones as new glycogen synthase kinase-3β inhibitors.
La Pietra V; La Regina G; Coluccia A; Famiglini V; Pelliccia S; Plotkin B; Eldar-Finkelman H; Brancale A; Ballatore C; Crowe A; Brunden KR; Marinelli L; Novellino E; Silvestri R
J Med Chem; 2013 Dec; 56(24):10066-78. PubMed ID: 24295046
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and anticancer activity of novel bisindolylhydroxymaleimide derivatives with potent GSK-3 kinase inhibition.
Winfield HJ; Cahill MM; O'Shea KD; Pierce LT; Robert T; Ruchaud S; Bach S; Marchand P; McCarthy FO
Bioorg Med Chem; 2018 Aug; 26(14):4209-4224. PubMed ID: 30026041
[TBL] [Abstract][Full Text] [Related]
28. Probing novel 1-aza-9-oxafluorenes as selective GSK-3beta inhibitors.
Voigt B; Krug M; Schächtele C; Totzke F; Hilgeroth A
ChemMedChem; 2008 Jan; 3(1):120-6. PubMed ID: 18000938
[TBL] [Abstract][Full Text] [Related]
29. Use of molecular modeling, docking, and 3D-QSAR studies for the determination of the binding mode of benzofuran-3-yl-(indol-3-yl)maleimides as GSK-3beta inhibitors.
Kim KH; Gaisina I; Gallier F; Holzle D; Blond SY; Mesecar A; Kozikowski AP
J Mol Model; 2009 Dec; 15(12):1463-79. PubMed ID: 19440740
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and in vitro characterization of 1-(4-aminofurazan-3-yl)-5-dialkylaminomethyl-1H-[1,2,3]triazole-4-carboxylic acid derivatives. A new class of selective GSK-3 inhibitors.
Olesen PH; Sørensen AR; Ursø B; Kurtzhals P; Bowler AN; Ehrbar U; Hansen BF
J Med Chem; 2003 Jul; 46(15):3333-41. PubMed ID: 12852764
[TBL] [Abstract][Full Text] [Related]
31. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
Hongisto V; Vainio JC; Thompson R; Courtney MJ; Coffey ET
Mol Cell Biol; 2008 Mar; 28(5):1515-27. PubMed ID: 18195042
[TBL] [Abstract][Full Text] [Related]
32. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases.
Polychronopoulos P; Magiatis P; Skaltsounis AL; Myrianthopoulos V; Mikros E; Tarricone A; Musacchio A; Roe SM; Pearl L; Leost M; Greengard P; Meijer L
J Med Chem; 2004 Feb; 47(4):935-46. PubMed ID: 14761195
[TBL] [Abstract][Full Text] [Related]
33. The first synthesis of [(11)C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3).
Wang M; Gao M; Miller KD; Sledge GW; Hutchins GD; Zheng QH
Bioorg Med Chem Lett; 2011 Jan; 21(1):245-9. PubMed ID: 21115250
[TBL] [Abstract][Full Text] [Related]
34. Glycogen synthase kinase-3 regulates formation of long lamellipodia in human keratinocytes.
Koivisto L; Alavian K; Hakkinen L; Pelech S; McCulloch CA; Larjava H
J Cell Sci; 2003 Sep; 116(Pt 18):3749-60. PubMed ID: 12890758
[TBL] [Abstract][Full Text] [Related]
35. GSK-3 beta inhibition and prevention of mitochondrial apoptosis inducing factor release are not involved in the antioxidant properties of SB-415286.
Yeste-Velasco M; Folch J; Jiménez A; Rimbau V; Pallàs M; Camins A
Eur J Pharmacol; 2008 Jul; 588(2-3):239-43. PubMed ID: 18502415
[TBL] [Abstract][Full Text] [Related]
36. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.
Jirousek MR; Gillig JR; Gonzalez CM; Heath WF; McDonald JH; Neel DA; Rito CJ; Singh U; Stramm LE; Melikian-Badalian A; Baevsky M; Ballas LM; Hall SE; Winneroski LL; Faul MM
J Med Chem; 1996 Jul; 39(14):2664-71. PubMed ID: 8709095
[TBL] [Abstract][Full Text] [Related]
37. N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy.
Tavares FX; Boucheron JA; Dickerson SH; Griffin RJ; Preugschat F; Thomson SA; Wang TY; Zhou HQ
J Med Chem; 2004 Sep; 47(19):4716-30. PubMed ID: 15341487
[TBL] [Abstract][Full Text] [Related]
38. Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders.
Furlotti G; Alisi MA; Cazzolla N; Dragone P; Durando L; Magarò G; Mancini F; Mangano G; Ombrato R; Vitiello M; Armirotti A; Capurro V; Lanfranco M; Ottonello G; Summa M; Reggiani A
J Med Chem; 2015 Nov; 58(22):8920-37. PubMed ID: 26486317
[TBL] [Abstract][Full Text] [Related]
39. PLS and shape-based similarity analysis of maleimides--GSK-3 inhibitors.
Crisan L; Pacureanu L; Avram S; Bora A; Avram S; Kurunczi L
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):599-610. PubMed ID: 24047148
[TBL] [Abstract][Full Text] [Related]
40. Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitors.
Crisan L; Avram S; Pacureanu L
Mol Divers; 2017 May; 21(2):385-405. PubMed ID: 28108896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
